Oriol Crusellas Maña

Oriol Crusellas Maña
Hospital de Sant Joan Despí Moisès Broggi | MOISESBROGGI · Department of General Surgery

Bachelor of Medicine

About

124
Publications
4,033
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
109
Citations
Citations since 2017
36 Research Items
109 Citations
2017201820192020202120222023051015202530
2017201820192020202120222023051015202530
2017201820192020202120222023051015202530
2017201820192020202120222023051015202530
Additional affiliations
March 2015 - present
Hospital de Barcelona. SCIAS
Position
  • Medical Doctor
May 2005 - May 2010
Hospital Clínic de Barcelona
Position
  • Residente

Publications

Publications (124)
Article
Aim We present a case of a recurrent parastomal hernia with enterocutaneous fistula and subcutaneous abscesses and their management. Material & Methods 79-year-old patient with history of pT4b low rectal cancer treated with an abdominoperineal resection with adjuvant chemo-radiotherapy in 2000. Parastomal hernia repair was performed in 2016 with P...
Article
Aim Report an unusual late complication after laparoscopic IPOM Material & Methods Description of a clinical case Results An 84 years old patient who had previously undergone laparoscopic IPOM with ePTFE mesh in 2012 for supraumbilical primary hernia, arrived to the emergency room in March 2022 with a small bowel obstruction due to an intralumina...
Article
Objective To study the effect of the incidence of parastomal hernia (PSH) through the prophylactic placement of a preformed intraperitoneal mesh in patients who must undergo a definitive colostomy. The comparison is made with a homogeneous control group that did not receive prophylactic mesh. Material and methods Unicentric, prospective, non-rando...
Article
Purpose Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) treatment has classically presented a percentage of associated complications that have limited its expansion. The aim of this study is to describe the morbimortality results obtained from a referral center implemented with the support of a governmental health...
Article
Full-text available
Introduction: Surgical planning for repair of giant hernias with loss of domain needs to consider patient comorbidities, potential risks and possible postoperative complications. Some postoperative complications are related to the increase in intra-abdominal pressure caused by the reintroduction of abdominal contents into the peritoneal space. Pre...
Article
Full-text available
The treatment of peritoneal metastases (PM) from colorectal cancer (CRC) has been revolutionized by the availability of cytoreductive surgery (CRS), traditionally coupled with Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC). The impact of HIPEC itself, over the effect of surgery is poorly understood and the presence of various HIPEC...
Article
Background: Gastrointestinal complications, predominantly anastomotic leak (AL), are the most frequent source of severe morbidity after cytoreductive surgery (CRS). Objective: The aim of this study was to present the technical standards for colorectal anastomoses developed and systematically applied to all patients undergoing CRS in a high-volum...
Article
36 Background: Surgical resection of peritoneal metastases of colorectal cancer (CRC PM) may benefit some patients similar to hepatic metastases. This approach remains controversial in part due to inconsistent selection criteria and reported outcomes. The impact of preoperative clinical characteristics and tumor molecular profiles on survival among...
Article
Full-text available
To describe a novel end-to-end “true” reinforced stapling colorectal anastomosis and to assess surgical outcomes in a large case series of advanced cancer patients undergoing this procedure.
Article
Full-text available
Objective To describe a novel end-to-end “true” reinforced stapling colorectal anastomosis and to assess surgical outcomes in a large case series of advanced cancer patients undergoing this procedure.Summary background dataAnastomotic leakage (AL) remains the main concern following surgery for colorectal cancer.Methods Between September 2006 and Ma...
Article
Full-text available
Introduction There has been an increase in the implantation of subcutaneous reservoirs in recent years. The objective of this study is to compare puncture techniques against venous dissection. Methods Retrospective cohort study. It included patients who required a Port-a-Cath. Patients were divided into two groups: venous puncture (PV) and venous...
Article
Full-text available
Background: Appendicitis is the most common general surgical emergency worldwide, but its diagnosis remains challenging. The aim of this study was to determine whether existing risk prediction models can reliably identify patients presenting to hospital in the UK with acute right iliac fossa (RIF) pain who are at low risk of appendicitis. Methods...
Article
Introduction: There has been an increase in the implantation of subcutaneous reservoirs in recent years. The objective of this study was to compare puncture techniques against venous dissection. Methods: This retrospective cohort study included patients who required a Port-a-Cath and were divided into two groups: venous puncture (PV) and venous...
Poster
Full-text available
CRS+HIPEC is a multimodal aggressive treatment usually performed on multitreated and weakened patients with a potential risk of complication. From this description a number of objections to its use have raised:: results of Sugarbaker difficult to reproduce, limited levels of evidence, highly aggressive, complex and expensive therapy, negative reper...
Poster
Full-text available
In 25% of colon cancer patients, peritoneal metastasis (PM) will be detected during follow up. Recent studies in selected group of patients with colorectal PM, treated with CRS+HIPEC and postoperative chemotherapy, report 5-y survival of 30-52%. Correct patient selection and surgical team experience are determining factors in the efficacy and safet...
Poster
Full-text available
PM from gastric origin is a rather frequent presentation. It is diagnosed at the time of initial surgical treatment in 15-50% of patients with gastric serosal involvement. Once it is present, it is associated with poor survival, with mean survivals from 3 to 9 months, and 0% survival at 5y. PM is the most common cause of therapeutic failure during...
Poster
Full-text available
Currently, about 75% of patients treated from an epithelial ovarian cancer relapse from their disease. Most of the recurrences will present on the peritoneum and these patients usually die despite the therapeutic protocol applied. Conventional treatments for recurrent ovarian cancer, systemic chemotherapy or chemotherapy and surgery, have shown a m...
Poster
Full-text available
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) is the gold standard for curative treatment of peritoneal metastasis (PM) arising from colorectal cancer, peritoneal mesothelioma and peritoneal pseudomyxoma peritonei (PMP). The results of HIPEC remain controversial in PM originated from ovarian cancer, gastric canc...
Article
Full-text available
Aim: CRS + HIPEC offers clinical benefits 0ver conventional treatment in certain types of Peritoneal Surface Malignancies (PSM). This type of treatment is performed with curative intent, and considered standard therapy in pseudomyxoma peritonei, peritoneal mesothelioma and PC from colorectal and appendiceal tumors. It is recommended in primary as w...
Article
Full-text available
Aim: Up to 25% of colorectal cancer patients will present PC during follow up. Numerous recent studies in selected group of patients with colorectal PC, treated with CRS + HIPEC and postoperative chemotherapy, report a 5-year survivals of 30-52%. The aggressiveness and surgical risk related to this treatment modality should outweigh the benefits ac...
Article
Aim: PC from gastric origin is a quite frequent manifestation. It is diagnosed at the time of initial surgical treatment in 15-50% of pt with gastric serosal involvement. Once it is present, it is associated with poor survival, with mean survival of 3-9 months, and 0% survival at 5y. PC is the most common cause of therapeutic failure during curativ...
Poster
Full-text available
Introducción La CP ha sido considerada una manifestación neoplasica terminal asociada a mala calidad de vida y tratada de forma paliativa con resultados de supervivencia muy escasos. En las últimas decadas han surgido nuevos enfoques terapéuticos de carácter radical que combinan la Cirugía Radical mediante los procedimientos de peritonectomías des...